These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8515748)

  • 1. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins].
    Ivanov KK
    Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial toxin vaccines.
    McDonel JL
    Adv Biotechnol Processes; 1990; 13():1-33. PubMed ID: 2110461
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification of bacterial exotoxins. The case of botulinum, tetanus, anthrax, pertussis and cholera toxins.
    Pasechnik VA; Shone CC; Hambleton P
    Bioseparation; 1992-1993; 3(5):267-83. PubMed ID: 1369426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.
    Hong HA; Ke NT; Nhon TN; Thinh ND; van der Gun JW; Hendriks JT; Kreeftenberg JG
    Bull World Health Organ; 1996; 74(3):275-82. PubMed ID: 8789926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vaccines against bacterial toxins.
    Rappuoli R; Pizza M; Douce G; Dougan G
    Adv Exp Med Biol; 1996; 397():55-60. PubMed ID: 8718582
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody titers of the commercially available human immunoglobulins against bacterial toxins and some opportunistic pathogens.
    Arai T; Komatsu S
    Kitasato Arch Exp Med; 1984 Sep; 57(3):243-6. PubMed ID: 6443134
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress toward development of an inhalation vaccine against botulinum toxin.
    Park JB; Simpson LL
    Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial toxin vaccines.
    Dorner F; McDonel JL
    Vaccine; 1985 Jun; 3(2):94-102. PubMed ID: 3929492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of diphtheria tetanus acellular pertussis combined (DTaP) vaccines in Japan.
    Horiuchi Y; Takahashi M; Konda T; Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y
    Jpn J Infect Dis; 2001 Oct; 54(5):167-80. PubMed ID: 11754154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of vaccines by the action of glutaraldehyde on toxins, bacteria, viruses, allergens, and cells.
    Relyveld EH; Ben-Efraim S
    Methods Enzymol; 1983; 93():24-60. PubMed ID: 6306393
    [No Abstract]   [Full Text] [Related]  

  • 12. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the molecular mechanism of action of bacterial toxins, in particular of diphtheria, cholera, coli, botulinum and shigella toxins as well as tetanospasmin and the toxins of staphylococcus aureus].
    Kolb E
    Z Gesamte Inn Med; 1984 Mar; 39(6):85-92. PubMed ID: 6375175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic detoxification of bacterial toxins: a new approach to vaccine development.
    Rappuoli R; Douce G; Dougan G; Pizza M
    Int Arch Allergy Immunol; 1995 Dec; 108(4):327-33. PubMed ID: 7580303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins.
    Robbins JB; Schneerson R; Trollfors B; Sato H; Sato Y; Rappuoli R; Keith JM
    J Infect Dis; 2005 Jan; 191(1):81-8. PubMed ID: 15593007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli.
    Aminian M; Sivam S; Lee CW; Halperin SA; Lee SF
    Protein Expr Purif; 2007 Feb; 51(2):170-8. PubMed ID: 16950635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial toxins: cellular mechanisms of action.
    Middlebrook JL; Dorland RB
    Microbiol Rev; 1984 Sep; 48(3):199-221. PubMed ID: 6436655
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of plant-derived recombinant DTP subunit vaccine.
    Brodzik R; Spitsin S; Pogrebnyak N; Bandurska K; Portocarrero C; Andryszak K; Koprowski H; Golovkin M
    Vaccine; 2009 Jun; 27(28):3730-4. PubMed ID: 19464556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.